Exploring Men s Prostate Cancer Genetic Risk Perceptions
Completed
Conditions studied: Prostate Cancer
In brief
The exploring men's prostate cancer genetic risk perceptions and willingness to give a biospecimen for genetic risk testing study aims to assess prostate cancer genetic risk and susceptibility beliefs among unaffected men of diverse races/ethnicities who are considering undergoing prostate cancer screening and their willingness of men to provide a biospecimen (saliva sample) and test the samples for prostate cancer aggressiveness and determine risk category based on SNP genetic profile.
Key facts
- Study ID
- NCT06764992
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
- People needed
- 100
- Starts
- 2022-08-25
- Expected to finish
- 2024-06-07
- Last updated by the study team
- 2026-02-04
Who can join
Age: 40 and older. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Racially/ethnically diverse men with emphasis on Men of African Ancestry.
- Age 40 and older .
- No personal prostate cancer history/diagnosis.
- With or without family history of prostate cancer.
You may not qualify if…
- Previous personal Prostate Cancer history/diagnosis
- Under 40 years of age
Where it is running
- Moffitt Cancer Center — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.